MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹27,755 Cr | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr |
What is the latest Total Liabilities ratio of MANKIND PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹27,755 Cr |
| Mar2025 | ₹27,652 Cr |
| Mar2024 | ₹11,883 Cr |
| Mar2023 | ₹9,686 Cr |
| Mar2022 | ₹9,108 Cr |
How is Total Liabilities of MANKIND PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27,755 Cr | 0.37 | |
| Mar2025 | ₹27,652 Cr | 132.70 | |
| Mar2024 | ₹11,883 Cr | 22.68 | |
| Mar2023 | ₹9,686 Cr | 6.34 | |
| Mar2022 | ₹9,108 Cr | - | |
Compare Total Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹99,078.7 Cr | 1.4% | -2.9% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
-2.9% |
-6.7% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses